Purple Biotech Ltd
TASE:PPBT
Purple Biotech Ltd
Revenue
Purple Biotech Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
P
|
Purple Biotech Ltd
TASE:PPBT
|
Revenue
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
T
|
Teva Pharmaceutical Industries Ltd
TASE:TEVA
|
Revenue
$15.8B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-2%
|
Taro Pharmaceutical Industries Ltd
NYSE:TARO
|
Revenue
$610.8m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-2%
|
|
I
|
InterCure Ltd
TASE:INCR
|
Revenue
₪414.8m
|
CAGR 3-Years
164%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
48%
|
Mediwound Ltd
NASDAQ:MDWD
|
Revenue
$18.7m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
41%
|
CAGR 10-Years
N/A
|
|
R
|
Rekah Pharmaceutical Industry Ltd
TASE:REKA
|
Revenue
₪315.3m
|
CAGR 3-Years
10%
|
CAGR 5-Years
9%
|
CAGR 10-Years
1%
|
See Also
What is Purple Biotech Ltd's Revenue?
Revenue
0
USD
Based on the financial report for Dec 31, 2022, Purple Biotech Ltd's Revenue amounts to 0 USD.